phenoxybenzamine and chloroethylnorapomorphine

phenoxybenzamine has been researched along with chloroethylnorapomorphine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldessarini, RJ; Kula, NS; Law, SJ; Neumeyer, JL1
Arana, GW; Baldessarini, RJ; Kula, NS; Law, SJ; Neumeyer, JL1

Other Studies

2 other study(ies) available for phenoxybenzamine and chloroethylnorapomorphine

ArticleYear
Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
    Journal of medicinal chemistry, 1980, Volume: 23, Issue:6

    Topics: Adenylyl Cyclase Inhibitors; Animals; Aporphines; Corpus Striatum; In Vitro Techniques; Phenoxybenzamine; Rats; Receptors, Dopamine

1980
Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
    European journal of pharmacology, 1980, Oct-03, Volume: 67, Issue:1

    Topics: Adenylyl Cyclases; Animals; Apomorphine; Aporphines; Cattle; Corpus Striatum; In Vitro Techniques; Phenoxybenzamine; Rats; Receptors, Dopamine

1980